ARS Wealth Advisors Group
GSK icon

ARS Wealth Advisors Group’s GSK GSK Stock Holding History

ARS Wealth Advisors Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.22M Buy
129,116
+1,478
+1% +$75.5K 0.45% 44
2026
Q2 		$6.69M Buy
127,638
+122
+0.1% +$6.45K 0.52% 42
2026
Q1 		$7.04M Buy
+127,516
New +$6.91M 0.59% 40
2022
Q4 		– Sell
-8,194
Closed -$241K – 143
2022
Q3 		$241K Sell
8,194
-121,942
-94% -$4.62M 0.04% 132
2022
Q2 		$7.08M Buy
+130,136
New +$7.18M 0.97% 38

Other funds holding GSK

Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Miller Howard Investments
Miller Howard Investments Kingston, New York $3.72B AUM 18.2% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
ABC Arbitrage
ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return
Foster Victor Wealth Advisors
Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return
Sound Income Strategies
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
Stockman Wealth Management
Stockman Wealth Management Billings, Montana $960M AUM 19.88% 1-Year Est. Return
Euro Pacific Asset Management
Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return

ARS Wealth Advisors Group's GSK Position: Q3 2026 in Review

ARS Wealth Advisors Group increased its GSK (GSK) stake by 1.2% in Q3 2026, buying an estimated $75.5K and bringing the position to 129,116 shares worth $6.22M. The position accounts for 0.45% of the portfolio, ranked #44.

ARS Wealth Advisors Group first reported a position in GSK in Q2 2022 and has held it in 5 quarters since. The position peaked at $7.08M in Q2 2022. 374 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • ARS Wealth Advisors Group held 129,116 shares of GSK worth $6.22M as of Q3 2026.
  • ARS Wealth Advisors Group bought 1,478 GSK shares in Q3 2026, an estimated $75.5K.
  • GSK made up 0.45% of ARS Wealth Advisors Group's portfolio in Q3 2026, its #44 holding.
  • ARS Wealth Advisors Group first reported a position in GSK in Q2 2022 and has held it in 5 quarters since.
  • ARS Wealth Advisors Group's GSK position peaked at $7.08M in Q2 2022.
  • 374 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on ARS Wealth Advisors Group's 13F filing for Q3 2026, filed 16 Oct 2026.